Physician
Doshi, Dipti
Doshi, Dipti was paid $486K by Medicaid between Apr 2018 and Oct 2024, across 12 billing codes. Its largest line is 99215, doctor's office visit, returning patient (complex) — 46% of everything it billed.
33Billing provider infoDOSHI, DIPTI
CERRITOS, CA 90703
CERRITOS, CA 90703
33aNPI1053325761assigned 07/28/2006
33bProvider typeRheumatology Physician
28Total paid$486K
24GClaims16,714
24DCodes billed12
24AFirst – last monthApr 2018 – Oct 2024
Compared with peers
Next to other Rheumatology Physician providers in California
Rank by total paid#34 of 147
Median peer was paid$43K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 993 | $6K | |
| 2019 | 1,967 | $47K | |
| 2020 | 1,370 | $46K | |
| 2021 | 2,611 | $99K | |
| 2022 | 4,363 | $159K | |
| 2023 | 3,638 | $100K | |
| 2024incomplete | 1,772 | $29K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 46% | 5,604 | 5,170 | $222K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 5,528 | 5,105 | $200K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.3% | 298 | 293 | $16K |
| 20553 | 2.2% | 586 | 575 | $11K | |
| 76881 | 1.9% | 499 | 451 | $9K | |
| 20610 | 1.5% | 440 | 425 | $8K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1.3% | 1,512 | 1,450 | $7K |
| M0220 | Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring | <1% | 31 | 26 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,014 | 961 | $4K |
| 99205 | Prolong outpt/office vis | <1% | 202 | 202 | $4K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 850 | 811 | $577.13 |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 150 | 129 | $571.65 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.